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Medical Science, Peking University, Beijing, ChinaABSTRACT Programmed cell death 5 (PDCD5) is a human apoptosis-related molecule that is involved in both the cytoplasmic
caspase-3 activity pathway (by regulating Bax translocation from cytoplasm to mitochondria) and the nuclear pathway (by inter-
acting with Tip60). In this study, we developed a mathematical model of the PDCD5-regulated switching of the cell response
from DNA repair to apoptosis after ultraviolet irradiation-induced DNA damage. We established the model by combining several
hypotheses with experimental observations. Our simulations indicate that the ultimate cell response to DNA damage is depen-
dent on a signal threshold mechanism, and the PDCD5 promotion of Bax translocation plays an essential role in PDCD5-regu-
lated cell apoptosis. Furthermore, the model simulations revealed that PDCD5 nuclear translocation can attenuate cell
apoptosis, and PDCD5 interactions with Tip60 can accelerate DNA damage-induced apoptosis, but the final cell fate decision
is insensitive to the PDCD5-Tip60 interaction. These results are consistent with experimental observations. The effect of re-
combinant human PDCD5 was also investigated and shown to sensitize cells to DNA damage by promoting caspase-3 activity.INTRODUCTIONDNA damage is a high-frequency event that occurs in living
cells. A mammalian genome undergoes ~100,000 modifica-
tions per day, each of which results in a finite probability of
residual damage (1). These damaging events can corrupt the
genetic information and threaten the health of an organism.
Therefore, a complex network of DNA damage responses
(DDRs) has evolved to sense and respond to DNA damage
(2). In multicellular organisms, activation of DDR results
in two primary responses: DNA repair and genomic restora-
tion or, if the damaged DNA cannot be sufficiently repaired,
execution of a cell death program such as apoptosis (3–6).
The molecular mechanism by which a cell makes the deci-
sion to promote survival (i.e., DNA repair) or death (i.e., by
triggering the apoptosis program) is not yet clear and
remains a challenging issue in cell biology (2).
Ultraviolet (UV) irradiation is commonly used in the
laboratory to induce DNA damage that can be detected by
the ataxia telangiectasia Rad3 related (ATR) protein,
a member of the ataxia telangiectasia mutated (ATM) family
of DNA damage sensors (7). ATM proteins bind directly to
free DNA ends and catalyze phosphorylation cascades to
transmit damage signals to cell cycle checkpoints and repair
proteins (8). Pathways downstream of the damage signals
interact with each other to regulate cell responses. Among
the downstream effects, the sumoylation of Tip60 and upre-
gulation of programmed cell death 5 (PDCD5) are crucial
for cell fate decisions, and both are associated with p53
signaling (9,10).
p53 is a core regulator of the decision between apoptosis
and other fates in response to DNA damage (11,12). ATMSubmitted June 16, 2011, and accepted for publication October 28, 2011.
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0006-3495/11/12/2582/10 $2.00proteins and other checkpoint activations lead to phosphor-
ylation of p53, which greatly increases its stability (2).
Several amino acids of p53 proteins are consistently phos-
phorylated and acetylated in response to different signals,
which then induce different downstream pathways, includ-
ing DNA repair, cell cycle arrest, and apoptosis (13).
Acetylation of p53 at lysine 120 (K120) can increase the
expression of the proapoptotic Bcl-2 family member protein
Bax. Phosphorylation of p53 at serine 20 (S20) allows p21
protein synthesis and subsequent G1 checkpoint activation.
p53 proteins can induce Mdm2, which in turn negatively
affects p53 levels, resulting in a negative feedback loop
(14). This feedback loop generates oscillations in both p53
and Mdm2 levels that are important in the mediation of
the DDR.
As mentioned above, Bax is a proapoptotic member of
the Bcl-2 family that is induced by p53 acetylation at
K120. After synthesis, Bax proteins are translocated to the
outer mitochondrial membrane, where they form channels
or even large holes for the release of cytochrome c into
the cytosol from the mitochondria (15). Once released, cyto-
chrome c associates with Apaf-1 (Apaf) and pro-caspase-9
to form apoptosomes. The apoptosome generates active
caspase-9, which then cleaves pro-caspase-3 to active
caspase-3 (15). Caspase-3 inactivates PARP and DNA-PK,
two key enzymes involved in the homeostatic maintenance
of genomic integrity, to disable the normal DNA repair
process and thereby induce apoptosis (16).
Tip60 is a histone acetyltransferase (HAT) that is
involved in the cellular response to DNA damage (9). In
response to DNA double-stranded breaks, Tip60 is recruited
to DNA lesions to participate in both the initial and final
stages of repair (17). Tip60 is also required for acetylation
of the endogenous p53 protein at K120, and therefore thedoi: 10.1016/j.bpj.2011.10.044
PDCD5-Regulated Cell Fate Decision 2583p53-dependent induction of proapoptotic target genes, such
as Bax, in response to DNA damage (18). Upon UV-irradi-
ation-induced DNA damage, the initial step of this pathway
involves site-specific sumoylation of Tip60 at lysines 430
(K430) and 451 (K451) via Ubc9. This sumoylation is
thought to be essential for DDR via a p53-dependent
pathway, because the inhibition of Tip60 sumoylation is
known to abrogate the p53-dependent DDR (9).
PDCD5 (formerly referred to as the TF-1 cell apoptosis-
related gene 19 (TFAR19)) is a novel gene that is known to
be related to the regulation of apoptosis (19). Decreased
expression of PDCD5 has been detected in various human
tumors, including astrocytic glioma (20), chondrosarcoma
(21), gastric cancer (22), lung cancer (23), and myelogenous
leukemia (24). A genome-wide study ranked the PDCD5
gene as the 47th most significant gene among a pool of
expressed genes in tumors (25), and overexpression of
PDCD5 in tumor cells has been found to enhance apoptosis
(19). The PDCD5 protein is apparently upregulated in cells
upon apoptotic stimulation (19), enhances caspase-3 activity
by modulating Bax translocation from the cytosol to the
mitochondrial membrane (26), and then translocates rapidly
from the cytoplasm to the nucleus by a yet unknown
mechanism (27). The latter event of PDCD5 nuclear trans-
location is suggested to be an early marker for apoptosis,
preceding the externalization of phosphatidylserine and
fragmentation of chromosome DNA, and occurs in parallel
with the loss of mitochondrial membrane potential (27).
This phenomenon is independent of both cell type and
apoptosis-inducing stimuli (27).
There are at least two known pathways through which
PDCD5 regulates cellular apoptosis. In the cytoplasm,
PDCD5 exerts its effects through the mitochondrial pathway
by modulating Bax translocation, cytochrome c release, and
caspase-3 activation, either directly or indirectly (26). Cells
with decreased expression of PDCD5 by short interfering
RNA against PDCD5 (siPDCD5) display reduced sensitivity
to an apoptotic stimulus by Bax overexpression. Knock-
down of PDCD5 expression in cells is known to result in
the attenuation of the cytochrome c released from the mito-
chondria to the cytosol, and the inhibition of both caspase-3
activity and pro-caspase-3 cleavage (26).
Another pathway of cellular apoptosis occurs in the
nucleus, where PDCD5 interacts with Tip60 and functions
as a cooperator in promoting Tip60 HAT activity and DNA
damage-induced apoptosis (10). PDCD5 can bind to Tip60
and enhance the stability of Tip60 proteins. The level of
binding is significantly increased after UV irradiation, which
enhances the HAT activity of Tip60 and Tip60-dependent
histone acetylation. Furthermore, PDCD5 increases Tip60-
dependent K120 acetylation of p53 and participates in the
p53-dependent expression of apoptosis-related genes (10).
Because the decreased expression of PDCD5 has been
characterized for some human tumors, recent studies have
focused on the potential clinical management of tumorsby recombinant human PDCD5 (rhPDCD5) (28–33).
RhPDCD5 was shown to enter a variety of cells by clathrin-
independent endocytosis (30), significantly facilitating
tumor cell apoptosis triggered by chemotherapy (31,32).
To understand the effect of rhPDCD5 therapy, we applied
our computational model in this study to quantitatively
assess the influence of PDCD5 pathways on the DDR.
Although the PDCD5 protein has been studied for more
than 10 years, and many interactions are known to be
involved in the DDR pathway, questions remain about the
importance of these interactions and how they cross talk
to regulate the cell fate decision. Our goal in this study
was to answer these questions with the use of a computa-
tional model.
Numerous studies have described computational models
of apoptosis pathways and DDRs (6,34–44). However,
most of these studies focused on either the cytoplasmic
pathway or p53 dynamics in the cellular response to DNA
damage, and little work has been performed for other parts
in the nuclear pathway. To the best of our knowledge, no
mathematical model has been presented for the PDCD5
regulatory pathways in this regard.
In this work, we attempted to establish such a model by
integrating known experimentally supported functions of
PDCD5, and to assess the importance of each PDCD5 inter-
action in the DDR pathways, as well as the connections
between these interactions.
To that end, we developed a mathematical model for
PDCD5-regulated cell fate decisions in response to UV-irra-
diation-induced DNA damage. In establishing the mathe-
matical model, we formed hypotheses in accordance with
experimental observations of the regulation of PDCD5
nuclear translocation, PDCD5 interactions with Tip60,
and PDCD5-mediated regulation of Bax translocation. We
tested these hypotheses by comparing our model simula-
tions with experimental evidence. Using the developed
model, we discuss mechanisms by which PDCD5 regulates
DNA damage-induced apoptosis. This work will provide
the basis for further investigations of PDCD5 regulation in
the DDR.MODEL AND METHODS
Model description
A schematic representation of the PDCD5 signaling network in response to
UV-irradiation-induced DNA damage is shown in Fig. 1. Our goal in this
study was to establish a model of the PDCD5 signaling pathway to under-
stand how PDCD5 regulates cell fate. Therefore, we omitted other signaling
pathways that may also be relevant for the DDR, but whose interconnec-
tions with PDCD5 regulation are not yet clear. For example, we omitted
the p53-Mdm2 regulation and simply assumed a time-dependent p53
dynamics after DNA damage (see the Supporting Material and Fig. S1
for discussions).
In our model, we considered cellular responses to UV-irradiation-
induced DNA damage, which is represented by ATR activity through the
following mechanism (45,46): The multisubunit replication protein (RPA)Biophysical Journal 101(11) 2582–2591
FIGURE 1 Schematic representation of the PDCD5 signaling network in response to UV-irradiation-induced DNA damage. State transitions and expres-
sions are represented by arrowheaded solid lines, and the promotions of state transition or cell response are denoted by circle-headed lines. Inhibitions of
protein activity or cell response are represented by bar-headed lines. Translocations are denoted by open arrowheaded dashed lines. Effects represented
by the black lines are based on experimental data and known facts from literatures. The blue lines indicate assumptions in the current study (see text for
details).
2584 Zhuge et al.complex has a high affinity for single-stranded DNA (ssDNA), which is
a common intermediate in the processing of many types of damaged
DNA, including double-strand breaks (DSBs), UV-induced thymidine
dimers, and mismatches in basepairing. Recruited by ssDNA-RPA com-
plexes at damage sites, ATR phosphorylates signal sensors/transducers
(such as Rad17 or a complex of Rad9p, Hus1p, and Rad1p), leading to
downstream responses of cell cycle arrest and DNA repair. For this reason,
relocalization of ATR to sites of damage has been the proposed mode of
ATR activation (45). ATR activation transmits DNA damage signals and
triggers multiple damage-response pathways (2). In response to these
signals, the expression of Tip60 and PDCD5 is rapidly upregulated, and
p53 levels also increase within minutes after damage.
The initial steps of the Tip60 regulation pathways involve the association
of Tip60 with SUMO-conjugation enzymes and site-specific sumoylation of
Tip60 at K430 and K451 (9). Tip60 sumoylation promotes its HAT activity,
which in turn induces DNA repair. Furthermore, Tip60 sumoylation recruits
p53 to the promyelocytic leukemia (PML) nuclear bodies to promote the
acetylation of p53 protein at K120 and phosphorylation at S20, leading
to expression of the proapoptotic protein Bax and the G1 arrest pathway,
respectively (9,18). The G1 arrest pathway was omitted from this study.
PDCD5 protein is weakly expressed and nearly evenly distributed in both
the cytoplasm and nucleus (27). After the onset of an apoptotic stimulus, the
cytoplasmic PDCD5 protein level first increases rapidly and then forms an
inward gradient from the cytoplasm to the nucleus (10,19,27). This pattern
is maintained for a few hours (with the duration dependent on the type of
cells and apoptosis stimulus) until the cytoplasmic PDCD5 proteins are
triggered to translocate and accumulate in the nucleus (27). As theBiophysical Journal 101(11) 2582–2591PDCD5 level in the nucleus becomes significantly higher than that in the
cytoplasm, the concentration gradient of PDCD5 inverts. The following
two observations are supported experimentally (27) (Fig. S2): 1), the
nucleus/cytoplasm ratio of the PDCD5 level is evidently <1 at the early
stage and >1 later on; and 2), the cytoplasmic PDCD5 level is obviously
decreased after nuclear translocation. We assume that the regulation of
PDCD5 nuclear translocation is incorporated in the form of a hypothetical
intermediary that is activated by a Tip60 downstream signal, and PDCD5
interactions with Tip60 can enhance the translocation activity (Fig. S3).
Our model includes two PDCD5 signaling pathways. In the cytoplasmic
pathway, PDCD5 increases the cleavage of pro-caspase-3 via enhancement
of Bax translocation from the cytosol to the mitochondrial outer membrane
(26). In the nucleus, PDCD5 proteins colocalize with Tip60, enhance the
stability of Tip60 (Fig. S5), and promote both Tip60 HAT activity and
K120 acetylation of p53 (Fig. S4) (10). Accordingly, we assume in our
model that the PDCD5 protein binds to Tip60, which increases its stability
and HAT activity, as well as the Tip60-induced K120 acetylation of p53.
Therefore, the PDCD5 protein is involved in both DNA repair and apoptotic
pathways.
Two feedback loops are shown in the model given in Fig. 1. When DNA
repair is triggered, the cells begin the repair processes, which decrease the
ATR activity and damage signals, resulting in a negative feedback loop.
The other feedback loop comes from caspase-3, which is activated through
increased Bax, cytochrome c release, and caspase-9 activation. The active
caspase-3 disables normal DNA repair processes by inactivating PARP and
DNA-PK (16). These regulatory processes form a positive feedback of
DNA damage after UV irradiation. To summarize the above explanations,
PDCD5-Regulated Cell Fate Decision 2585we argue that there are essentially two signaling pathways involving PDCD5
proteins that lead to a cell fate decision after DNA damage: the nuclear
pathway that is controlled by the interaction of PDCD5 with Tip60, and
the cytoplasmic pathway that is controlled by PDCD5-regulated Bax
translocation. Moreover, the nuclear pathway is involved in both feedback
loops, whereas the cytoplasmic pathway only contributes to the positive
feedback.Formulations
The model in Fig. 1 can be formulated as a set of differential equations for
the dynamics of molecular concentrations (or activities). There are five vari-
ables in our differential equation model: the concentrations of PDCD5
proteins in the nucleus [P]nu and cytoplasm [P]cyt, sumoylated Tip60 [T],
the Tip60-PDCD5 complex (in nucleus) [TP], and ATR activity [A]. The
dynamic processes of these quantities are modeled by a set of five ordinary
differential equations. In addition, the total p53 protein concentration is
assumed to be an increase function of the ATR activity. Other quantities
in the model, including the HAT activity [H], p53 acetylation level [p53],
concentration of Bax protein [Bax], and caspase-3 activity [C3], are
assumed to depend on [P]nu, [P]cyt, [T], [TP], and [A] instantaneously by
applying quasi-equilibrium assumptions.
In the differential equations, the following biological processes are
modeled: increased expression of Tip60 and PDCD5 after DNA damage,
increased p53 level in response to DNA damage, nuclear translocation of
PDCD5, cross nuclear membrane diffusion of PDCD5, binding and disso-
ciation of Tip60 and PDCD5 in the nucleus, degradation of the molecules,
and regulation of ATR activity through the DNA repair and apoptosis path-
ways. The complete model equations are given in the Supporting Material,
with the following key assumptions taken into consideration:
The production rates of Tip60 and PDCD5 are increase functions of the
ATR activity [T].
The ATR activation rate is proportional to the degree of DNA damage,
and decreases with respect to the Tip60 HAT activity and increases
with caspase-3 activity.
PDCD5 binds to sumoylated Tip60 to promote its HAT activity.
PDCD5 binds to sumoylated Tip60 to promote K120 acetylation of p53.
Furthermore, the total p53 level increases with ATR activity.
In the cytoplasm pathway, PDCD5 promotes caspase-3 activity by regu-
lating Bax translocation from the cytoplasm to the mitochondrial
outer membrane, and Bax expression is upregulated by the K120
acetylated of p53.
PDCD5 nuclear translocation is regulated by a Tip60 downstream
signal, and PDCD5 interactions with Tip60 can enhance this translo-
cation.
Parameter estimation
We estimated the model parameters according to available experimental
results for UV-irradiation-induced apoptosis in U2OS cells (Fig. S4 and
Fig. S5), such that our model yields a bistable response, i.e., a cell response
to DNA damage with either success or failure in repairing the DNA
sequence depending on stimulus strengths (Fig. S6). Details are provided
in the Supporting Material.METHODS
Numerical simulation
In numerical simulations, we solved the model equations with the NDSolve
function on theMathematica 6.0 platform (47). Initial conditions were set to
the steady state before the stimulus was applied. In each case, we solved the
equations to t ¼ 40 h until the solutions reached a steady state, to mimic
a UV-irradiation treatment of 40 h.Multicell simulation
To simulate various responses of a group of cells, which are essentially
different from each other, we modeled each individual cell by varying
each model parameter randomly and independently within a range
of 520% of its default value (as given by Table S1). We kept the Hill
coefficients unchanged because they usually relate to the qualitative prop-
erties of the interactions, which are the same for different cells of the same
type. Thus, for a group of cells, we had an ensemble of sets of different
parameter values. For each set of parameters, we solved the model equation
with the above numerical method to obtain the response of a particular cell.
The apoptosis probability could therefore be obtained by statistical calcula-
tions based on the simulation results of this group of cells. This procedure is
described as multicell simulation. When we studied the dependence of
the apoptosis probability on a particular parameter, we applied a multicell
simulation in which the value of the given parameter was fixed while other
parameters were randomly changed.RESULTS
Threshold triggering of a cellular response
to DNA damage
To determine how cells respond to DNA damage with
stimuli of different strengths, we numerically solved
the model equations with stimulus strength vA varied from
10–4 to 2  10–2. The resulting time courses of ATR and
caspase-3 activities are shown in Fig. 2, a and b. The results
show a significant threshold mechanism of DDR. When the
stimulus was low, ATR and caspase-3 activities were low at
40 h, indicating successful DNA repair. There was an
obvious threshold (at approximately vA ¼ 0.0025) of the
stimulus strength, such that when the stimulus was beyond
the threshold, ATR and caspase-3 activities were high at
40 h, indicating a failure of DNA repair and initiation of
apoptosis.
Fig. 2 a shows obvious two-phase dynamics in ATR
activity when the stimulus strength was high. The first phase
occurred in the early stage, when ATR activities increased
due to the appearance of damage signals, followed by
a decrease in response to DNA repair. When the stimulus
strength was low, DNA repair signals dominated the cellular
responses, such that ATR activity decreased to a steady low-
level state. However, when the stimulus strength was high,
a second phase of increased ATR activity appeared in
parallel with the increase of caspase-3 activity (Fig. 2 b).
These results suggest that the second phase of ATR induc-
tion was due to the increase in caspase-3 activity, which in
turn inhibited the DNA repair. A two-phase dynamic profile
was also seen under strong stimulation in a recent study of
a p53 network model of DDR (43). It is not clear whether
there are any connections between these two-phase
dynamics, and this issue requires further studies and exper-
imental validation.
Caspase-3 activation is usually considered as a marker of
apoptosis induction, and therefore its activity can be used to
characterize the probability of apoptosis. Fig. 2 c shows
caspase-3 activity at 40 h as a function of stimulus strength.Biophysical Journal 101(11) 2582–2591
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FIGURE 2 Simulation of cellular response to
DNA damage with a threshold mechanism. (a)
Time courses of ATR activities with different
stimulus strengths (vA). The arrow shows the direc-
tion of increasing vA from 10
–4 to 10–2 with
a step of 410–4 (same as in b). (b) Time courses
of caspase-3 activities with different stimulus
strengths. (c) Caspase-3 activity at 40 h after stim-
ulation as a function of stimulus strength for
control cells (v2¼ 1.3910–3) and siPDCD5-trans-
fected cells (v2 ¼ 4.6310–4) are superimposed on
the activity at steady state (lines). Other parameters
are the same as described in Table S1. (d) Depen-
dence on stimuli thresholds (vA) for induction
of apoptosis with varying PDCD5 expression
rate (v2), binding rate of PDCD5 to Tip60 (kon),
efficiency of regulating Bax translocation by
PDCD5 (a), and nuclear translocation rate (k0).
The horizontal axis shows the ratio of each value
to the corresponding default value. In each case,
other parameters were taken as their default values.
The threshold is defined as the value of stimulus
strength vA such that caspase-3 activity is 0.5 at
40 h of stimulus.
2586 Zhuge et al.The result shows a clear transition from low to high activity
at approximately vA ¼ 0.0025. We also examined the
activity of siPDCD5-transfected cells in which the PDCD5
expression rate was reduced to one-third as in wild-type
cells. A transition from low to high was also seen in
siPDCD5 cells, but the threshold (approximately vA ¼
0.0118) was much larger than that for wild-type cells.
This result indicates that decreased expression of PDCD5
can inhibit apoptosis, in agreement with previously reported
experiments (10,19,26).
Furthermore, we examined how the stimulus threshold for
apoptosis induction depends on PDCD5 regulations. To that
end, we individually changed the PDCD5 expression rate
(v2), binding rate of PDCD5 to Tip60 (kon), efficiency of
regulating Bax translocation by PDCD5 (a), and PDCD5
nuclear translocation rate (k0) (of course, keeping other
parameters unchanged) to find the corresponding threshold
(Fig. 2 d). The results show that the threshold decreased
significantly when either v2 or a increased, and increased
with k0, but was insensitive to changes in kon. These results
suggest that the well-tuned PDCD5 expression rate v2 and
regulation efficiency a are important for cell response.
Note that in our model, the PDCD5 cytoplasmic pathway
is described by the parameter a, and the PDCD5 nuclear
pathway is described by kon. The above results indicate
that the apoptotic threshold is more sensitive to the
PDCD5 cytoplasmic pathway than to the PDCD5 nuclear
pathway.
In Fig. 2 c, we note that for wild-type cells, the threshold
for inducing apoptosis (vA ¼ 0.0025) was consistent withBiophysical Journal 101(11) 2582–2591the bifurcation point of the high-to-low switch obtained
from steady-state analysis (point A in Fig. S6, vA ¼
0.0025) rather than the bifurcation point of the low-to-
high switch (point B in Fig. S6, vA ¼ 0.0097), as we
expected. For siPDCD5-transfected cells, the threshold was
between the two bifurcation points from the steady-state
analysis (Fig. 2 c). These observations differ from what is
known from bistability analysis, in which the threshold
should be consistent with the bifurcation at a low-to-high
switch (34,35,38).We argue that this is due to the appearance
of the second phase of increased ATR activity, as discussed
above,which could switch the cell response fromDNA repair
(low ATR and caspase-3 activities) to apoptosis (high ATR
and caspase-3 activities), although the state of DNA repair
was stable. Such a switch can be seen in time courses of
molecular concentrations/activities (Fig. S7) in which the
rapid increase in caspase-3 activity at ~2 h of simulation
was evident, triggering apoptosis and stopping the DNA
repair process. Experimental observations of such a rapid
pulse-like increase in caspase-3 activity in p53-induced
apoptosis were previously reported (48,49).PDCD5 enhancement of caspase-3 activity is
required for DNA-damage-induced apoptosis
PDCD5 is known to promote apoptosis by modulating Bax
translocation, cytochrome c release, and caspase-3 activa-
tion (26). Here, using our model, we investigated how
PDCD5 enhancement of caspase-3 activity would affect
the cell response after DNA damage.
PDCD5-Regulated Cell Fate Decision 2587In our model, we formulated the caspase-3 activity as
a Hill-type function of Bax concentration, with the half-
maximal effective concentration (EC50) dependent on cyto-
plasmic PDCD5 concentration (see Supporting Material):
½C3 ¼ cmax ½Bax
n
Kn þ ½Baxn; K ¼
Km
1þ

a½Pcyt
m: (1)
Here the coefficient a represents the efficiency of cyto-
plasmic PDCD5 proteins, with a larger a-value indicating
higher efficiency.
In previous simulations, the stimulus threshold to induce
apoptosis sensitively depended on the efficiency a, with
larger a-values yielding lower thresholds (Fig. 2 d). To
further investigate the role of PDCD5 regulation, we
changed the efficiency a from zero to double the default
value, and solved the equations. Fig. 3 a shows the simula-
tion results for ATR and caspase-3 activity dynamics with
different efficiencies. In contrast to the two-phase dynamics
of cell response to DNA damage described above, here,
when the efficiency a was small, ATR activity increased
only once at the early stage (Fig. 3 a). When the efficiency
was large, however, the ATR activity displayed the second
phase of increase, in parallel with the increase of caspase-
3 activity, and both remained at a high-level steady state.
These results suggest that the first induction phase of ATR
activity was independent of the efficiency a, whereas the
second phase was promoted by the increased efficiency.
Fig. 3 b shows the simulation result of the timing of the
second phase of ATR activity when it first crossed 3.0, as
a function of the efficiency a. There was a minimum effi-
ciency (a ¼ 1.72), such that the second phase would not
appear if a was smaller than this value; otherwise, the
second phase would occur, the timing of which decreased
with increasing a. As noted above, the second increase
phase was required to switch the cell response from DNA
repair to apoptosis. These results suggest that PDCD5     
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FIGURE 3 Simulated cell responses with different efficiencies of
PDCD5 regulating Bax translocation. (a) Time course of ATR activity
(upper panel) and caspase-3 activity (lower panel). Arrows show directions
of increasing a from 0 to 4 with a step of 0.4. The dashed line shows ATR
activity of 3.0 (an indicator of the second phase of ATR induction). (b)
Dependence of the timing of the second phase activity on the efficiency
a (see text for details). Stimulus strength vA ¼ 0.0026.modulation of caspase-3 activation in the cytoplasmic
pathway is essential for DNA-damage-induced cell
apoptosis.PDCD5 nuclear translocation can attenuate
DNA-damage-induced cell apoptosis
Previous experimental findings suggested that PDCD5
nuclear translocation is an early event for apoptosis (27).
However, the role of this event in the cellular response to
DNA damage (in particular, whether it is an apoptosis
trigger or an early consequent signal of apoptosis) remains
unclear.
In previous simulations, we showed that increasing the
rate of PDCD5 nuclear translocation yielded a higher stim-
ulus threshold for apoptosis induction (Fig. 2 d). To further
investigate the reason for this dependence, we studied
the dynamic behaviors of cytoplasmic PDCD5 concentra-
tions and caspase-3 activity while varying the PDCD5
nuclear translocation rate (Fig. 4 a). A direct consequence
of PDCD5 nuclear translocation was a decrease in the cyto-
plasmic PDCD5 concentration, which in turn attenuated
caspase-3 activity. When the translocation was off (k0 ¼
0), the cytoplasmic PDCD5 level increased with time in
response to DNA damage, thereby sustaining the caspase-3
activity at a high level. When k0 was increased, the cyto-
plasmic PDCD5 level decreased after the activation of its
nuclear translocation, causing the caspase-3 activity to be
reduced to a low level (Fig. 4 a). To further validate the
above observation, we calculated the apoptosis probability
using the multicell simulation method. Fig. 4 b shows the
obtained apoptosis probability as a function of k0, which
decreased with increasing k0. These results suggest that
PDCD5 nuclear translocation may not be necessary for
DNA-damage-induced apoptosis, and increasing the     
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FIGURE 4 Simulation results for cellular responses with different values
of PDCD5 nuclear translocation rate. (a) Time courses of cytoplasmic
PDCD5 concentration (upper panel) and caspase-3 activity (lower panel),
with k0 ¼ 410–4 (down triangles), k0 ¼ 210–4(up triangles), and
k0¼ 0 (circles). Arrows show the directions of increasing k0. (b) Simulation
result of apoptosis probability as a function of k0. The probability was
obtained by the multicell simulation method (see Materials and Methods
for details). A cell was identified as apoptotic if its caspase-3 activity
was >0.5 at 40 h of simulation. Stimulus strength vA ¼ 0.0026.
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2588 Zhuge et al.translocation rate can instead attenuate apoptosis by
decreasing the cytoplasmic PDCD5 concentration. We spec-
ulate that PDCD5 nuclear translocation is not a triggering
signal for apoptosis, and is more likely to be an early subse-
quent event of apoptosis.DNA-damage-induced apoptosis is unlikely
sensitive to PDCD5 interactions with Tip60
Previous experimental results showed that PDCD5 interacts
with Tip60 and functions as a cooperator in acetyltransfer-
ase activity and DNA-damage-induced apoptosis (10). To
examine the effects of PDCD5 interactions with Tip60, we
changed the association rate kon of PDCD5 binding to
Tip60 and solved the model equations. Fig. 5 a shows
the simulated caspase-3 activity with kon increased from
zero to double the default value. These results revealed
that turning off the PDCD5 interaction could attenuate
apoptosis, and increasing the binding rate could accelerate
the increasing phase of caspase-3 activity, thereby acceler-
ating DNA-damage-induced apoptosis, in agreement with
experimental observations (10). We also noted that the final
activity was insensitive to the binding rate when kon was
away from zero (for example, larger than one-fifth of the
default value). Furthermore, Fig. 5 b shows the apoptosis
probability obtained by the multicell simulation method,
which displayed a weak dependence on the binding rate
kon. These results suggest that DNA-damage-induced
apoptosis is insensitive to the PDCD5 interactions with
Tip60. It would be of interest to further clarify the signifi-
cance of this interaction in vivo.rhPDCD5 sensitizes cells to DNA damage
by promoting caspase-3 activity
The simulations described above showed that ourmodel qual-
itatively agreeswellwith experimental observations.Next,we
applied the model to study how rhPDCD5 can affect DNA-
damage-induced cell apoptosis. To that end, we replaced
the cytoplasmic PDCD5 production rate vP ([A]) by vrh þ vP
([A]), where vrh is a constant representing the increased rate
of cytoplasmic PDCD5 proteins due to the injection of0 10 20 30 40
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Biophysical Journal 101(11) 2582–2591rhPDCD5. Furthermore, we assumed that rhPDCD5 proteins
share same functions as endogenous PDCD5.
Fig. S8 shows the simulation results of apoptosis proba-
bilities for wild-type and siPDCD5 treated cells, with and
without rhPDCD5, as functions of stimulus strength. The
results show that administration of rhPDCD5 increased the
apoptosis probability for both wild-type and siPDCD5 cells,
but this effect was more significant for siPDCD5 cells than
for wild-type cells. As noted above, the modulation of cyto-
plasmic PDCD5 proteins to caspase-3 activity was impor-
tant for PDCD5-regulated cell apoptosis. Thus, the effect
of rhPDCD5 was mainly due to the increase of cytoplasm
PDCD5 proteins, which enhanced caspase-3 activity.
Finally, in Fig. S8, we note that in the case of a weak
stimulus and after rhPDCD5 administration, the apoptosis
probabilities showed an even decreased dependence on the
stimulus strength vA. This is a result of decreased cyto-
plasmic PDCD5 protein concentration due to PDCD5
nuclear translocation.DISCUSSION
PDCD5 is a novel gene that is involved in the determination
of cell fate after DNA damage (10,19), and decreased
expression of PDCD5 has been detected in various human
tumors (20–22,24). In cells undergoing apoptosis, the
PDCD5 level in the cytoplasm is rapidly upregulated. At
least two pathways may be involved in PDCD5-mediated
enhancement of apoptosis. In the nucleus, PDCD5 interacts
with Tip60 to promote both Tip60 HAT activity and Tip60-
dependent K120 acetylation of p53, the latter of which
increases the proapoptotic Bcl-2 family genes and induces
apoptosis (10). In the cytoplasm, decreased expression of
PDCD5 was found to attenuate cell apoptosis and caspase-
3 activity induced by Bax expression, which suggests that
PDCD5 may modulate caspase-3 activity through a cyto-
plasmic pathway (26). In recent studies, rhPDCD5 was
found to facilitate tumor cell apoptosis triggered by chemo-
therapy (31–33). Therefore, overexpression of PDCD5 can
enhance cell apoptosis, and administration of rhPDCD5
may have an important role in cancer chemotherapy. Never-
theless, to improve the safety of its use in clinical practice,1.5 2
 default value)
FIGURE 5 Simulation of cellular response to
different binding rates of PDCD5 interactions
with Tip60. (a) Dynamics of caspase-3 activity
with kon increasing from zero to double the default
value. The arrow shows the direction of increasing
kon. (b) Apoptosis probability as a function of kon.
The probability was obtained by the multicell
simulation method (see Materials and Methods
for details). A cell was identified as apoptotic if
its caspase-3 activity was >0.5 at 40 h after stimu-
lation. Stimulus strength vA ¼ 0.0026.
PDCD5-Regulated Cell Fate Decision 2589there is a pressing need to uncover the molecular mecha-
nism by which PDCD5 accelerates cellular apoptosis, and
to quantitatively investigate its role in the cell fate decision
after chemotherapy.
In this study, we attempted to quantitatively study the
PDCD5-regulated cell fate decision after UV-irradiation-
induced DNA damage. We developed a mathematical model
for the regulatory pathways of PDCD5 in response to DNA
damage. In this model, the PDCD5 protein level in the cyto-
plasm is upregulated after DNA damage, and cytoplasmic
PDCD5 proteins can enhance caspase-3 activity by modu-
lating Bax translocation. The two PDCD5 signaling path-
ways included in our model are based on experimental
observations. In the cytoplasmic pathway, the PDCD5
proteins promote caspase-3 activity by facilitating the trans-
location of Bax from the cytosol to the outer membrane of
the mitochondria. In the nuclear pathway, the PDCD5
protein binds to Tip60, thereby stabilizing it and promoting
its HAT activity and Tip60-dependent p53 acetylation at
K120. The two pathways are connected by PDCD5 nuclear
translocation. Our model includes two feedback loops for
the DNA damage signal that is represented by ATR activity:
1), a negative feedback loop through the DNA repair
pathway that tends to reduce the damage signal; and 2),
a positive feedback through the apoptosis pathway that
tends to increase the damage signal. Thus, the cell fate
decision depends on the competition between these two
pathways. The PDCD5 nuclear pathway is contained in
both feedback loops, whereas the cytoplasmic pathway is
involved only in the positive feedback loop.
We propose several crucial hypotheses based on experi-
mental observations (10,26,27): 1) PDCD5 nuclear translo-
cation is regulated by a Tip60 downstream signal, and this
signal can be enhanced by PDCD5. 2) PDCD5 binds to
Tip60 to form a complex, and this complex can stabilize
Tip60, promote its HATactivity, and enhance K120 acetyla-
tion of p53. 3) Cytoplasmic PDCD5 promotes caspase-3
activity by regulating Bax translocation from the cytoplasm
to the outer membrane of the mitochondria.
We estimated the model parameters in accordance with
experimental results from apoptotic U2OS cells induced
by UV irradiation. The model equations were solved numer-
ically on the Mathematica 6.0 platform. To minimize the
effect of specific parameter values, we applied the method
of multicell simulation in which parameters are taken
randomly within a range 520% of their default values.
Using the multicell simulations, we obtained apoptosis
probabilities of a group of cells whose parameters are
random over the given range.
Our simulations showed that cells respond to DNA
damage with apoptosis triggered at a certain threshold.
The threshold was shown to be sensitive to the PDCD5
expression rate and the efficiency of PDCD5-promoted
caspase-3 activation, but insensitive to the PDCD5 nuclear
translocation rate and the binding rate of PDCD5 toTip60. In particular, PDCD5-enhancing caspase-3 activity
is required for DNA-damage-induced apoptosis.
On the basis of our simulations, we propose the following
simplified model of PDCD5-regulated apoptosis after DNA
damage (Fig. S9):
1. After DNA damage occurs, expressions of Tip60 and
PDCD5 are upregulated, and the p53 level increases
rapidly. PDCD5 proteins are mostly distributed in the
cytoplasm. Meanwhile, the Tip60 HAT activity is acti-
vated and initiates the DNA repair process.
2. Tip60 induces K120 acetylation of p53, which in turn
upregulates the expression of Bax. PDCD5 interactions
with Tip60 can enhance the K120 acetylation of p53.
3. Bax proteins translocate from the cytosol to mitochon-
dria outer membranes and promote the release of
cytochrome c, which induces caspase-3 activation. Cyto-
plasmic PDCD5 proteins can enhance caspase-3 activa-
tion by modulating Bax translocation.
4. Caspase-3 inhibits the DNA repair process and activates
apoptosis. PDCD5 nuclear translocation is an early
signal of apoptosis, associated with an accumulation of
PDCD5 proteins in the nucleus.
Finally, we applied our model to study how rhPDCD5
enhances cell apoptosis after DNA damage, which is often
an effect of cancer chemotherapy. The results suggest that
administration of rhPDCD5 sensitized cells to DNA damage
by promoting caspase-3 activity through the cytoplasmic
pathway.
Many previous studies involving computational models
of damage responses (6,40–44) concentrated on the cell
fate decision mediated by p53, which is considered to be
a key regulator in the genetic network of DDR. However,
in this study we focused on a less-studied protein,
PDCD5, which was not considered in previous models.
This protein is involved in the DDR network through several
interactions. Thus, the proposed model of PDCD5 interac-
tions can be considered an extension of the known compu-
tational models of DDR. This extension provides a more
comprehensive understanding of cell-fate decisions after
DNA damage, and is important for investigations of the
development of rhPDCD5 in cancer therapy.
To our knowledge, this study is the first attempt to
establish a computational model for PDCD5-regulated
determination of the cell fate decision after DNA damage.
We chose to focus on the PDCD5-related molecular regula-
tory networks, and omitted other signaling pathways that are
involved in cell fate decisions but do not have a clear rela-
tion to PDCD5. This simplification was meant to help us
elucidate the specific molecular mechanism of PDCD5
signaling. Nevertheless, a more complete signaling network
is certainly necessary to enhance our understanding of cell
fate decisions in response to DNA damage. Additional
work in this direction is required before our model can be
applied within a larger context.Biophysical Journal 101(11) 2582–2591
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